Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083410
Filing Date
2025-06-06
Accepted
2025-06-06 21:03:02
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 17972
  Complete submission text file 0000950170-25-083410.txt   19482
Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Hallal David (Reporting) CIK: 0001457477 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39401 | Film No.: 251032649

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Issuer) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)